SEARCH

SEARCH BY CITATION

References

  • 1
    Wilcox AJ & Skjaerven R. Birth weight and perinatal mortality: the effect of gestational age. American Journal of Public Health 1992; 82:378382.
  • 2
    McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. New England Journal of Medicine 1985; 312:8290.
  • 3
    Breslau N. Psychiatric sequelae of low birth weight. Epidemiologic Reviews 1995; 17:96106.
  • 4
    Goldenberg RL. Editorial: Intrauterine infection and why preterm prevention programs have failed. American Journal of Public Health 1996; 86:781783.
  • 5
    Villar J & Belizan JM. The relative contribution of prematurity and fetal growth retardation to low birth weight in developing and developed societies. American Journal of Obstetrics and Gynecolology 1982; 143:793798.
  • 6
    Parry S & Strauss JF III Premature rupture of the fetal membranes. New England Journal of Medicine 1998; 338:663670.
  • 7
    Goepfert AR & Goldenberg RL. Prediction of prematurity. Current Opinion in Obstetrics and Gynecology 1996; 8:417427.
  • 8
    Kelly T. The pathophysiology of premature rupture of the membranes. Current Opinion in Obstetrics and Gynecology 1995; 7:140145.
  • 9
    Lopez Bernal A, Watson SP, Phaneuf S, Europe-Finner GN. Biochemistry and physiology of preterm labour and delivery. Baillieres Clinical Obstetrics and Gynaecology 1993; 7:523552.
  • 10
    Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infectious Disease Clinics of North America 1997; 11:135176.
  • 11
    Andrews WW, Goldenberg RL, Hauth JC. Preterm labor: emerging role of genital tract infections. Infectious Agents and Disease 1995; 4:196211.
  • 12
    Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. New England Journal of Medicine 1988; 319:972978.
  • 13
    Lockwood CJ, Wein R, Lapinski R, Casal D, Berkowitz G, Alvarez M, et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. American Journal of Obstetrics and Gynecology 1993; 169:798804.
  • 14
    Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. American Journal of Obstetrics and Gynecology 1995; 173:606612.
  • 15
    Harrison HR, Alexander ER, Weinstein L, Lewis M, Nash M, Sim DA. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA 1983; 250:17211727.
  • 16
    Sweet RL, Landers DV, Walker C, Schachter J. Chlamydia trachomatis infection and pregnancy outcome. American Journal of Obstetrics and Gynecology 1987; 156:824833.
  • 17
    Claman P, Toye B, Peeling RW, Jessamine P, Belcher J. Serologic evidence of Chlamydia trachomatis infection and risk of preterm birth. Canadian Medical Association Journal 1995; 153:259262.
  • 18
    Hay PE, Lamont RF, Taylor Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. British Medical Journal 1994; 308:295298.
  • 19
    Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. New England Journal of Medicine 1995; 333:17371742.
  • 20
    Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Lou Y, et al.Colonization with group B streptococci in pregnancy and adverse outcome. Vaginal Infections and Prematurity Study Group. American Journal of Obstetrics and Gynecology 1996; 174:13541360.
  • 21
    Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sexually Transmitted Diseases 1997; 24:353360.
  • 22
    McDonald HM, O'Loughlin JA, Jolley PT, Vigneswaran R, McDonald PJ. Changes in vaginal flora during pregnancy and association with preterm birth. Journal of Infectious Diseases 1994; 170:724728.
  • 23
    Krohn MA, Thwin SS, Rabe LK, Brown Z, Hillier SL. Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications. Journal of Infectious Diseases 1997; 175:606610.
  • 24
    Krohn MA, Hillier SL, Lee ML, Rabe LK, Eschenbach DA. Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. Journal of Infectious Diseases 1991; 164:8893.
  • 25
    Eschenbach DA. Ureaplasma urealyticum and premature birth. Clinical Infectious Diseases 1993; 17 (Suppl. 1): S100S106.
  • 26
    Knudsin RB, Driscoli SG, Monson RR, Yeh C, Biano SA, Cochran WD. Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality. New England Journal of Medicine 1984; 310:941945.
  • 27
    Kundsin RB, Leviton A, Allred EN, Poulin SA. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstetrics and Gynecology 1996; 87:122127.
  • 28
    Valkunberg MH, Essed GGM, Potters HVPJ. Perinatal listeriosis underdiagnosed as a cause of preterm labour? European Journal of Obstetrics, Gynecology and Reproductive Biology 1988; 27:283288.
  • 29
    Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. New England Journal of Medicine 1995; 333:17321736.
  • 30
    Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. American Journal of Obstetrics and Gynecology 1994; 171:345347.
  • 31
    Imseis HM, Greig PC, Livengood CH, 3rd, Shunior E, Durda P, Erikson M. Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. Journal of the Society for Gynecologic Investigation 1997; 4:9094.DOI: 10.1016/s1071-5576(97)00003-8
  • 32
    Rizzo G, Capponi A, Rinaldo D, Tedeschi D, Arduini D, Romanini C. Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. American Journal of Obstetrics and Gynecology 1996; 175:812817.
  • 33
    Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstetrics and Gynecology 1993; 81:941948.
  • 34
    Murtha AP, Greig PC, Jimmerson CE, Roitman-Johnson B, Allen J, Herbert WN. Maternal serum interleukin-6 concentrations in patients with preterm premature rupture of membranes and evidence of infection. American Journal of Obstetrics and Gynecology 1996; 175:966969.
  • 35
    Moore KW, Ho ASY, Xu-Amano J. Molecular biology of interleukin-10 and its receptor. In: Interleukin-10. Editors: de Vries JE, de Waal Malefyt R.) Austin: REG Landes Co, 1995; pp. 110.
  • 36
    Boulay JL & Paul WE. The interleukin-4-related lymphokines and their binding to hematopoietin receptors. Journal of Biological Chemistry 1992; 267:2052520528.
  • 37
    Sporn MB & Roberts AB. Transforming growth factor-beta: recent progress and new challenges. Journal of Cell Biology 1992; 119:10171021.
  • 38
    Greig PC, Herbert WN, Robinette BL, Teot LA. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. American Journal of Obstetrics and Gynecology 1995; 173:12231227.
  • 39
    Dudley DJ, Hunter C, Mitchell MD. Amniotic fluid interleukin-10 (IL-10) concentrations during and with labor. Journal of Reproductive Immunology 1997; 33:127136.DOI: 10.1016/s0165-0378(97)00012-0
  • 40
    Hata T, Kawamura T, Fujiwaki R, Aoki S, Hata K, Inada K. Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood. Gynecologic and Obstetric Investigation 1997; 43:155157.
  • 41
    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:16441655.
  • 42
    Kilpatrick DC, Bevan BH, Liston WA. Association between mannan binding protein deficiency and recurrent miscarriage. Human Reproduction 1995; 10:25012505.
  • 43
    Littell RC, Milliken GA, Stroup WW, Wolfinger RD SAS. System for Mixed Models. Cary, NC: SAS Publishing. 1996.
  • 44
    Verbeke G & Molenberghs G. Linear Mixed Models in Practice. A SAS-Oriented Approach. New York: Springer-Verlag, 1997.
  • 45
    Thorsen P, Jensen IP, Ebbesen N, Arpi M, Bremmelgaard A, Jeune B, et al. Few microorganisms may constitute the pathological core of bacterial vaginosis. A population based microbiological study among 3596 pregnant women. American Journal of Obstetrics and Gynecology 1998; 178:580587.
  • 46
    Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. Journal of Clinical Investigation 1997; 99:7787.
  • 47
    Kaufmann SH. Heat shock proteins and the immune response. Immunology Today 1990; 11:129136.
  • 48
    Retzlaff C, Yamamoto Y, Hoffman PS, Friedman H, Klein TW. Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infection and Immunity 1994; 62:56895693.
  • 49
    Svinarich DM, Wolf NA, Gomez R, Gonik B, Romero R. Detection of human defensin 5 in reproductive tissues. American Journal of Obstetrics and Gynecology 1997; 176:470475.
  • 50
    Masera RG, Muscettola M, Tanganelli C, Grasso G, Bateman A, Solomon S, et al. In vitro effects of peptides of the corticostatin/defensin family on production of mitogen-induced cytokines. Annali Italiani di Medicina Interna 1995; 10:113118.
  • 51
    Balazovich KJ, Suchard SJ, Remick DG, Boxer LA. Tumor necrosis factor-alpha and FMLP receptors are functionally linked during FMLP-stimulated activation of adherent human neutrophils. Blood 1996; 88:690696.
  • 52
    Chimura T, Hirayama T, Takase M. Lysozyme in cervical mucus of patients with chorioamnionitis. Japanese Journal of Antibiotics 1993; 46:726729.
  • 53
    Petersen LK, Skajaa K, Uldbjerg N. Serum relaxin as a potential marker for preterm labour. British Journal of Obstetrics and Gynaecology 1992; 99:292295.
  • 54
    Unemori EN & Amento EP. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. Journal of Biological Chemistry 1990; 265:1068110685.
  • 55
    McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nature Medicine 1995; 1:460463.
  • 56
    Paez Pereda M, Sauer J, Perez Castro C, Finkielman S, Stalla GK, Holsboer F, et al. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 1995; 136:55045510.
  • 57
    Mazor M, Hershkowitz R, Ghezzi F, Cohen J, Silber A, Levy J, et al. Maternal plasma and amniotic fluid 17 beta-estradiol, progesterone and cortisol concentrations in women with successfully and unsuccessfully treated preterm labor. Archives of Gynecology and Obstetrics 1996; 258:8996.DOI: 10.1007/s004040050106
  • 58
    Rogers JT. Ferritin translation by interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996; 87:25252537.
  • 59
    Goldenberg RL, Tamura T, DuBard M, Johnston KE, Copper RL, Neggers Y. Plasma ferritin and pregnancy outcome. American Journal of Obstetrics and Gynecology 1996; 175:13561359.
  • 60
    Van Der Poll T, Van Deventer SJ, Hack CE, Wolbink GJ, Aarden LA, Buller HR, et al. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 1992; 79:693698.
  • 61
    Oleszczuk J, Wawrzycka B, Maj JG. Interleukin-6 and neopterin levels in serum of patients with preterm labour with and without infection. European Journal of Obstetrics, Gynecology and Reproductive Biology 1997; 74:2730.DOI: 10.1016/s0301-2115(97)00083-3
  • 62
    Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, et al. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. American Journal of Obstetrics and Gynecology 1993; 168:18521856.
  • 63
    Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstetrics and Gynecology 1996; 88:816822.
  • 64
    Benn PA, Horne D, Briganti S, Rodis JF, Clive JM. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstetrics and Gynecology 1996; 87:217222.
  • 65
    Wang W & Alpert E. Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein. Hepatology 1995; 22:921928.
  • 66
    Neki R, Matsuzaki N, Yamanaka K, Shimoya K, Okada T, Saji F, et al. The interleukin-6 (IL-6) /IL-6-receptor system induces human chorionic gonadotropin production by activating tyrosine kinase-dependent signal transduction pathway different from pathways triggered by protein kinase activators including gonadotropin releasing hormone. Journal of Clinical Endocrinology and Metabolism 1993; 77:704709.
  • 67
    McGregor JA, Jackson GM, Lachelin GC, Goodwin TM, Artal R, Hastings C, et al. Salivary estriol as risk assessment for preterm labor. a prospective trial. American Journal of Obstetrics and Gynecology 1995; 173:13371342.
  • 68
    Zuckerman SH, Ahmari SE, Bryan-Poole N, Evans GF, Short L, Glasebrook AL. Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia. Inflammation 1996; 20:581597.
  • 69
    Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, Poulsen K, et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386:506510.
  • 70
    Laham N, Brennecke SP, Bendtzen K, Rice GE. Tumour necrosis factor alpha during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues. European Journal of Endocrinology 1994; 131:607614.
  • 71
    Greig PC, Ernest JM, Teot L, Erikson M, Talley R. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. American Journal of Obstetrics and Gynecology 1993; 169:10351044.
  • 72
    Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, et al.Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. American Journal of Obstetrics and Gynecology 1996; 174:14331440.
  • 73
    Fidel PL Jr, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, et al.Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. American Journal of Obstetrics and Gynecology 1994; 170:14671475.
  • 74
    Romero R, Gomez R, Galasso M, Brandt F, Cotton DB, Dinarello CA, et al.The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: the effect of gestational age, fetal gender, and intrauterine infection. American Journal of Obstetrics and Gynecology 1994; 171:912921.
  • 75
    Lockwood CJ. Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventative therapies. Current Opinion in Obstetrics and Gynecology 1994; 6:718.
  • 76
    Briese V. Current aspects of premature labor. Zentralblatt fur Gynakologie 1995; 117:393401.
  • 77
    Jensen IP, Thorsen P, Jeune B, Møller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. British Journal of Obstetrics and Gynaecology 2000; 107:637643.